Historical record - last NADAC effective date: 6/2/2017
Product Information
FOSRENOL 500 MG TABLET CHEW is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $11.6417 per EA under NDC 54092025290. Its NADAC has been published 238 times since Nov 28, 2013.
FDA first approved this application on Oct 26, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lanthanum carbonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092025290
Classification
Brand
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
6/2/2017
Active Ingredients
LANTHANUM CARBONATEApproval Type
New Drug (NDA)
FDA Application
NDA021468FDA Approved
10/26/2004
TE Code
AB
On Market Since
10/26/2004
Pharmacological Classes
Price Statistics
The NADAC for FOSRENOL 500 MG TABLET CHEW has been published 238 times since Nov 28, 2013, and over the history we have for it it has risen 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.6417 per EA |
|---|---|
| All-time high | $11.6417 (Jun 13, 2018) |
| All-time low | $7.3546 (Nov 28, 2013) |
| Median price | $9.7875 |
| Average price | $9.8484 |
| Largest weekly change | +9.0% (Jan 8, 2014) |
| Weeks tracked | 238 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+58.3%
Last surveyed Jun 13, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lanthanum carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lanthanum carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOSRENOL 500 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for FOSRENOL 500 MG TABLET CHEW, manufactured by Takeda Pharmaceuticals America, Inc., is $11.6417 per EA (NDC 54092025290), effective Jun 13, 2018.
How has the price of FOSRENOL 500 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for FOSRENOL 500 MG TABLET CHEW has risen 58.3%. It has been tracked across 238 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FOSRENOL 500 MG TABLET CHEW?
Since Nov 28, 2013, the NADAC for FOSRENOL 500 MG TABLET CHEW has ranged from a low of $7.3546 (Nov 28, 2013) to a high of $11.6417 (Jun 13, 2018), with a median of $9.7875 per EA.
Are there cheaper alternatives to FOSRENOL 500 MG TABLET CHEW?
No other NADAC-published product currently shares the active ingredient and strength of FOSRENOL 500 MG TABLET CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FOSRENOL 500 MG TABLET CHEW?
FOSRENOL 500 MG TABLET CHEW (NDC 54092025290) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.